EGFR and lung cancer: Experimental analyses of MR30 were performed in lung cancer cells representative of a disease for which EGFR inhibitors are indicated [32, 50] and melanoma cells deriving from a tumour type for which methyldiazonium generators such as dacarbazine and TMZ are indicated [34].